Company Filing History:
1 out of 23 
1 out of 932 
Years Active: 2025
Title: Aron Roxin: Innovator in Theranostic Compounds
Introduction
Aron Roxin is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of theranostics, particularly with his innovative patent that combines diagnostic and therapeutic capabilities.
Latest Patents
Roxin holds a patent for "Dual mode 18F-labelled theranostic compounds and uses thereof." This invention involves a compound or molecular complex that includes a metal chelator designed for chelation with either a radioactive or non-radioactive isotope. Additionally, it features a trifluoroborate (BF)-containing moiety configured for F/F exchange or a precursor thereof, and optionally, a cell-targeting domain. This patent represents a significant advancement in the development of targeted therapies.
Career Highlights
Throughout his career, Aron Roxin has worked with prominent organizations such as the Provincial Health Services Authority and The University of British Columbia. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Roxin has collaborated with notable colleagues, including David Perrin and Mathieu Lepage. These partnerships have further enhanced his research and innovation in theranostic compounds.
Conclusion
Aron Roxin's contributions to the field of theranostics through his innovative patent and collaborations with esteemed colleagues highlight his role as a significant inventor in the medical research community. His work continues to pave the way for advancements in targeted therapies.